In this episode, the focus is on significant shifts in the AI landscape. The episode begins with a look at the stock market turmoil and DeepSeek's AI breakthrough, setting the stage for a discussion on the global tech landscape transformation. Michelle highlights Google's strategy of democratizing AI by making its Gemini 2.5 Pro model free, examining its implications. The conversation extends to Zhipu AI's introduction of a free agent and its performance benchmarks. In the realm of healthcare, the episode explores Weill Cornell's use of AI in precision medicine, specifically in cancer treatment models. The episode concludes with insights into AI's role in personalized cancer treatment and future visions for the field.

(0:00) Stock Market Turmoil and DeepSeek's AI Breakthrough

(1:21) Global Tech Landscape Transformation

(2:05) Google's Gemini 2.5 Pro Goes Free

(3:33) Democratizing AI: Google's Strategy

(3:53) Zhipu AI's Free Agent and Performance Benchmarks

(6:15) AI in Precision Medicine: Weill Cornell's Cancer Treatment Model

(8:14) AI's Role in Personalized Cancer Treatment and Future Vision